Stock

Immunic, Inc. IMUX

$14.49-1.70%

All stocks Create account to unlock

Overview

IMUX market data

Price History

IMUX price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for IMUX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

6 captured

8-K filing — IMMUNIC, INC. (IMUX) · Jul 14, 2026, 12:01 PM

EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO · May 27, 2026, 10:17 AM

EXCLUSIVE: Immunic Appoints Former Genentech Executive Erik Lundgren As CEO To Fire Up MS Drug Launch; He Joins Effective May 22, Employment Begins June 1 · May 27, 2026, 10:16 AM

B. Riley Securities Maintains Buy on Immunic, Lowers Price Target to $27 · May 22, 2026, 2:20 PM

Earnings Scheduled For May 13, 2026 · May 13, 2026, 11:11 AM

Immunic Q1 EPS $(1.08) Misses $(0.91) Estimate · May 13, 2026, 10:34 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock